Martínez Portillo FJ et al., 2002-04: Spanish-language report of 25 patients with priapism (22 drug-induced after intracavernous injection therapy, 1 leukaemic, 2 high-flow) treated with 5 mL intracavernous methylene blue after corporeal aspiration – the larger series from the same author group as MTN-33 (printed affiliation on this record: University of Kiel, Germany).
25 patients were treated for priapism. Etiologies were: 22 drug-mediated (PGE1 or papaverine/phentolamine mixture) after corpus cavernosum injection therapy (CCIT)
Martínez Portillo FJ et al., 2002-04: Spanish-language report of 25 patients with priapism (22 drug-induced after intracavernous injection therapy, 1 leukaemic, 2 high-flow) treated with 5 mL intracavernous methylene blue after corporeal aspiration – the larger series from the same author group as MTN-33 (printed affiliation on this record: University of Kiel, Germany). C7 (also C11, Spanish). Study type: clinical series (indexed as Clinical Trial, English abstract). N: 25 patients, ages 13-72. Country: Germany (Heidelberg group; published in Archivos Espanoles de Urologia). Dose: 5 mL of MB intracavernously, left 5 min, aspirated, compression 5 min; concentration not stated. Funder/conflicts: none declared in the record. Comparator: none. Original-language title: '[Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents]' – the Spanish title is in the PubMed record and the abstract read here is the English one. Also filed as MTQ-068 (claims C7). Study type: uncontrolled series.
